1.
Ramasubbu SK, Dakshinamurthy S, Palepu S, Bandyopadhyay A, Rajendran SK. Rimegepant: first novel oral calcitonin gene-related peptide inhibitor for migraine. Int J Basic Clin Pharmacol [Internet]. 2020 Apr. 23 [cited 2025 Jul. 13];9(5):829-32. Available from: https://www.ijbcp.com/index.php/ijbcp/article/view/4120